Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.359 EUR
1.16 B EUR
76.47 B EUR
1.34 B
About SINOPHARM GROUP CO. LTD.
Sector
Industry
Headquarters
Shanghai
Website
Founded
2003
ISIN
CNE100000FN7
FIGI
BBG000VZC5B0
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
The time to wake up the stock of giant Sinopharm is nearSinopharm Group is a profitable Chinese state company with 2 covid-19 vaccines (the first is approved in China) with very strong fundamentals (except debt).
Sinopharms stock seems to be near the end of a many years correction, ready to reverse its declining trend.
Next follows the stocks mid-ter
SinoPharma Elliott Wave estimate@HKex Start of Wave 3 with price estimates and time bounded by ellipse ;)
Health is wealth , agreed ?Some may not agree and that is fine !
Think for a moment. Many of us spent a lot of time working in our career, clocking hours after office hours hoping to gain that year end promotion, score that bonus or simply act out of peer pressure.
Take a minute to read this article I found.
I am of t
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where X2S is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SINOPHARM GRP CO. H YC 1 stocks are traded under the ticker X2S.
We've gathered analysts' opinions on SINOPHARM GRP CO. H YC 1 future price: according to them, X2S price has a max estimate of 3.41 EUR and a min estimate of 2.20 EUR. Watch X2S chart and read a more detailed SINOPHARM GRP CO. H YC 1 stock forecast: see what analysts think of SINOPHARM GRP CO. H YC 1 and suggest that you do with its stocks.
Yes, you can track SINOPHARM GRP CO. H YC 1 financials in yearly and quarterly reports right on TradingView.
SINOPHARM GRP CO. H YC 1 is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
X2S earnings for the last half-year are 0.15 EUR per share, whereas the estimation was 0.18 EUR, resulting in a −13.77% surprise. The estimated earnings for the next half-year are 0.19 EUR per share. See more details about SINOPHARM GRP CO. H YC 1 earnings.
SINOPHARM GRP CO. H YC 1 revenue for the last half-year amounts to 37.85 B EUR, despite the estimated figure of 40.02 B EUR. In the next half-year revenue is expected to reach 40.50 B EUR.
X2S net income for the last half-year is 479.74 M EUR, while the previous report showed 620.23 M EUR of net income which accounts for −22.65% change. Track more SINOPHARM GRP CO. H YC 1 financial stats to get the full picture.
Yes, X2S dividends are paid annually. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (TTM)% is 4.36%. Tracking SINOPHARM GRP CO. H YC 1 dividends might help you take more informed decisions.
SINOPHARM GRP CO. H YC 1 dividend yield was 4.67% in 2023, and payout ratio reached 29.82%. The year before the numbers were 4.54% and 28.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 115.96 K employees. See our rating of the largest employees — is SINOPHARM GRP CO. H YC 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINOPHARM GRP CO. H YC 1 EBITDA is 3.24 B EUR, and current EBITDA margin is 4.38%. See more stats in SINOPHARM GRP CO. H YC 1 financial statements.
Like other stocks, X2S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINOPHARM GRP CO. H YC 1 stock right from TradingView charts — choose your broker and connect to your account.